Skip to main content
. Author manuscript; available in PMC: 2017 Mar 15.
Published in final edited form as: Immunity. 2016 Mar 2;44(3):647–658. doi: 10.1016/j.immuni.2016.02.006

Figure 7. IgG against Murein Lipoprotein Confers Protection against Salmonella Infection.

Figure 7

(A–C) GF mice were i.p. administered PBS or 107 WT or ΔMLP E. coli. 2 weeks later, the concentrations of serum IgG, IgA, and IgM against fecal bacteria were determined by ELISA (A), and the presence of anti-MLP IgG in the sera of these mice were also confirmed by immunoprecipitation of MLP from WT E. coli lysates and immunoblotted using sera from these mice or monoclonal anti-MLP (B). 2–3 weeks after administration of PBS or 107 CFU of WT and or ΔMLP E. coli, GF mice were i.p. infected with 104 CFU of Salmonella M525P and the levels in spleens and livers were determined at 72 hr (C).

(D and E) Salmonella were incubated with anti-MLP IgG or isotype for 30 min, and then assessed for surface IgG coating (D) and killing by neutrophils in vitro (E). 6- to 8-week-old WT mice were i.p. administered 1 mg of anti-MLP IgG or isotype for 24 hr before i.p. infection with 4 × 104 ST M525P. CFU of ST M525P in spleens and livers were determined at 72 hr.

Data represent two to three independent experiments. Error bars indicate SD. *p < 0.05, **p < 0.01,

***p < 0.001. See also Figure S6.

HHS Vulnerability Disclosure